Literature DB >> 23825493

Maggot debridement therapy for peripheral arterial disease.

Kimihiro Igari1, Takahiro Toyofuku, Hidetoshi Uchiyama, Shinya Koizumi, Koji Yonekura, Toshifumi Kudo, Masatoshi Jibiki, Norihide Sugano, Yoshinori Inoue.   

Abstract

INTRODUCTION: Maggots are potent debriding agents capable of removing necrotic tissue and slough; however, it is still unclear which wounds are most likely to benefit from maggot debridement therapy (MDT). Thus, we performed this retrospective review to gain insight into the patient and therapy characteristics influencing outcome. PATIENTS AND METHODS: We reviewed patients with foot ulcers caused by critical limb ischemia, encountered during the period between June 2005 and May 2010. The treatment outcomes were defined as effective or ineffective.
RESULTS: There were 16 patients with 16 leg ulcers. The patients were 13 men and 3 women, with an average age of 67.2 years (range, 47-85 years). Ten (63%) of the 16 ulcers were treated effectively. According to univariate analyses, an ankle brachial pressure index (ABI) lower than 0.6 (p = 0.03) had a negative impact on the outcome of MDT; however, outcome was not influenced by gender, obesity, ischemic heart disease, diabetes mellitus, hemodialysis, smoking, or laboratory findings.
CONCLUSIONS: Some patient characteristics, such as gender, obesity, ischemic heart disease, diabetes mellitus, hemodialysis, and smoking, do not seem to contraindicate eligibility for MDT. However, a limb with an ABI lower than 0.6 is less likely to benefit. (English Translation of J Jpn Coll Angiol 2011; 51: 209-213.).

Entities:  

Keywords:  foot ulcer; maggot debridement therapy; necrotic foot; peripheral arterial disease

Year:  2013        PMID: 23825493      PMCID: PMC3692982          DOI: 10.3400/avd.oa.13-00036

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  17 in total

Review 1.  Medicinal maggots: an ancient remedy for some contemporary afflictions.

Authors:  R A Sherman; M J Hall; S Thomas
Journal:  Annu Rev Entomol       Date:  2000       Impact factor: 19.686

2.  Larva therapy in wound management.

Authors:  M Courtenay; J C Church; T J Ryan
Journal:  J R Soc Med       Date:  2000-02       Impact factor: 5.344

3.  Biodebridement: a case report of maggot therapy for limb salvage after fourth-degree burns.

Authors:  N Namias; J E Varela; R P Varas; O Quintana; C G Ward
Journal:  J Burn Care Rehabil       Date:  2000 May-Jun

Review 4.  Biosurgery in wound healing--the renaissance of maggot therapy.

Authors:  U Wollina; K Karte; C Herold; A Looks
Journal:  J Eur Acad Dermatol Venereol       Date:  2000-07       Impact factor: 6.166

5.  Maggot therapy for the treatment of diabetic foot ulcers.

Authors:  K Y Mumcuoglu; A Ingber; L Gilead; J Stessman; R Friedmann; H Schulman; H Bichucher; I Ioffe-Uspensky; J Miller; R Galun; I Raz
Journal:  Diabetes Care       Date:  1998-11       Impact factor: 19.112

6.  The traditional use of maggots in wound healing, and the development of larva therapy (biosurgery) in modern medicine.

Authors:  J C Church
Journal:  J Altern Complement Med       Date:  1996       Impact factor: 2.579

7.  The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers.

Authors:  S O Oyibo; E B Jude; I Tarawneh; H C Nguyen; D G Armstrong; L B Harkless; A J Boulton
Journal:  Diabet Med       Date:  2001-02       Impact factor: 4.359

8.  Maggot therapy for the treatment of intractable wounds.

Authors:  K Y Mumcuoglu; A Ingber; L Gilead; J Stessman; R Friedmann; H Schulman; H Bichucher; I Ioffe-Uspensky; J Miller; R Galun; I Raz
Journal:  Int J Dermatol       Date:  1999-08       Impact factor: 2.736

9.  Larval therapy--an effective method of ulcer debridement.

Authors:  H Wolff; C Hansson
Journal:  Clin Exp Dermatol       Date:  2003-03       Impact factor: 3.470

10.  A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems.

Authors:  J L Ballard; C C Eke; T J Bunt; J D Killeen
Journal:  J Vasc Surg       Date:  1995-10       Impact factor: 4.268

View more
  2 in total

1.  Combined arterial reconstruction and free tissue transfer for patients with critical limb ischemia.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Masatoshi Jibiki; Yoshinori Inoue; Kentaro Tanaka; Mutsumi Okazaki
Journal:  Ann Vasc Dis       Date:  2013-11-15

2.  Comparison of Larval Therapy and Vacuum-Assisted Closure Therapy after Revascularization in Peripheral Artery Disease Patients with Ischemic Wounds.

Authors:  Ugur Cangel; Serhat Sirekbasan; Erdal Polat
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.